2011
DOI: 10.1128/cvi.05260-11
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Evaluation of MPT83 (Rv2873) for T Helper-1 Cell Reactivity and Identification of HLA-Promiscuous Peptides in Mycobacterium bovis BCG-Vaccinated Healthy Subjects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 65 publications
0
18
0
Order By: Relevance
“…The ProPred analysis has previously been shown to identify immunodominant antigens and peptides of several M. tuberculosis proteins [28][30], [39], [40]. The overall results of ProPred analysis suggest that PPE68 was a promiscuous HLA-DR binder (Table 3).…”
Section: Discussionmentioning
confidence: 96%
“…The ProPred analysis has previously been shown to identify immunodominant antigens and peptides of several M. tuberculosis proteins [28][30], [39], [40]. The overall results of ProPred analysis suggest that PPE68 was a promiscuous HLA-DR binder (Table 3).…”
Section: Discussionmentioning
confidence: 96%
“…Complex mycobacterial antigens and synthetic peptides of M. tuberculosis RD1. The complex mycobacterial antigens used in this study were whole-cell M. bovis BCG (ATCC 19015) [18], M. tuberculosis H37Rv [19], M. tuberculosis cell walls (MT-CW) [20], and M. tuberculosis culture filtrate (MT-CF) collected from in vitro midterm culture [21]. MT-CW and MT-CF were provided by J.T.…”
Section: Methodsmentioning
confidence: 99%
“…MPT83 is a surface‐exposed glycosylated lipoprotein that has widely been attributed to function in host cell adhesion. It is expressed as a strong immunogenic antigen in both M. tuberculosis and with 100% homology in M. bovis where it is called MPB83 . In cattle it induces strong T‐cell responses, and due to antibody generation as early as 4 weeks after infection it is a promising marker for serodiagnosis.…”
Section: Lipoprotein‐based Immunizationmentioning
confidence: 99%